Literature DB >> 17912565

Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy.

Irena Tsui1, Daniel Casper, Chai Lin Chou, Stephen H Tsang.   

Abstract

Topiramate is known to cause ocular side effects such as refractive changes and angle closure. We describe a patient with an electronegative electroretinogram (ERG) which may have been related to topiramate use. Electronegative ERG's have been associated with other drugs in humans as well as topiramate use in rabbits. However, this would be the first suggestion of causality in humans.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17912565      PMCID： PMC2750026          DOI： 10.1007/s10633-007-9084-7

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN： 0012-4486            Impact factor:   2.379


  5 in total

Review 1.  [Macular vitelliform degeneration in adults. Retrospective study of a series of 85 patients].

Authors:  A Glacet-Bernard; G Soubrane; G Coscas
Journal:  J Fr Ophtalmol       Date:  1990       Impact factor: 0.818

2.  Retinal function and histopathology in rabbits treated with Topiramate.

Authors:  S Kjellström; A Bruun; B Isaksson; T Eriksson; S Andréasson; V Ponjavic
Journal:  Doc Ophthalmol       Date:  2006-11-18       Impact factor: 2.379

3.  [EOG in adult vitelliform macular degeneration, butterfly-shaped pattern dystrophy and Best disease].

Authors:  M Theischen; H Schilling; U H Steinhorst
Journal:  Ophthalmologe       Date:  1997-03       Impact factor: 1.059

4.  [Severe ocular side effects with Topamax].

Authors:  V M Asensio-Sánchez; B Torreblanca-Agüera; S Martínez-Calvo; M J Calvo; R Rodríguez
Journal:  Arch Soc Esp Oftalmol       Date:  2006-06

Review 5.  Molecular pharmacology of topiramate: managing seizures and preventing migraine.

Authors:  H Steve White
Journal:  Headache       Date:  2005-04       Impact factor: 5.887
  5 in total
  7 in total

1.  Topiramate maculopathy.

Authors:  William Gualtieri; Jan Janula
Journal:  Int Ophthalmol       Date:  2012-09-28       Impact factor: 2.031

2.  Topiramate and visual loss in a patient carrying a Leber hereditary optic neuropathy mutation.

Authors:  Steno Rinalduzzi; Anna Maria Cipriani; Neri Accornero
Journal:  Neurol Sci       Date:  2011-09-07       Impact factor: 3.307

3.  Cellular origin of fundus autofluorescence in patients and mice with a defective NR2E3 gene.

Authors:  N-K Wang; H F Fine; S Chang; C L Chou; W Cella; J Tosi; C-S Lin; T Nagasaki; S H Tsang
Journal:  Br J Ophthalmol       Date:  2009-05-07       Impact factor: 4.638

4.  Deferoxamine-induced electronegative ERG responses.

Authors:  Ruben Jauregui; Karen Sophia Park; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2018-05-16       Impact factor: 2.379

Review 5.  General pathophysiology in retinal degeneration.

Authors:  Katherine J Wert; Jonathan H Lin; Stephen H Tsang
Journal:  Dev Ophthalmol       Date:  2014-04-10

6.  Topiramate and the vision: a systematic review.

Authors:  Mohammad-Ali Abtahi; Seyed-Hossein Abtahi; Farhad Fazel; Peyman Roomizadeh; Masoud Etemadifar; Keivan Jenab; Mojtaba Akbari
Journal:  Clin Ophthalmol       Date:  2012-01-12

7.  Topiramate-induced maculopathy in IgG4-related disease.

Authors:  Joanna DaCosta; Saad Younis
Journal:  Drug Healthc Patient Saf       Date:  2016-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.